Financial statements Ryneczek-Bio

Balance sheet of Ryneczek-Bio

Company age:
Age:
3 y. 9 m. 30 d.
Share capital:
Share capital:
10 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of RYNECZEK-BIO

Year
2021
2023
Total assets 144 992,53 401 128,02
A. Fixed assets 9 850,90 5 471,30
B. Current assets 135 141,63 395 656,72
C. Share capital contributions (basic funds) - -
D. Own shares (stocks) - -
Total liabilities 144 992,53 401 128,02
A. Equity 18 469,67 303 078,08
B. Liabilities and provisions for liabilities 126 522,86 98 049,94
I. Long-term liabilities - -
II. Short-term liabilities 126 522,86 98 049,94
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.